Trupanion, Inc. (TRUP)
| Previous close | 32.82 |
| Open | 32.70 |
| Bid | 30.84 x 100 |
| Ask | 31.04 x 100 |
| Day's range | 30.72 - 33.25 |
| 52-week range | 18.45 - 36.66 |
| Volume | |
| Avg. volume | 788,590 |
| Market cap | 1.302B |
| Beta (5Y monthly) | 1.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.64 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 33.57 |
GlobeNewswireTrupanion Comments on Rate Filing Approval in California
SEATTLE, May 17, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) today provided the following update on its rate filing approval status in California. The California Department of Insurance approved a 29% rate increase, which is in addition to its previously approved 12% rate increase in June of 2023. The new rate will go into effect during late July 2024. The rising cost of veterinary care amplifies the need for Trupanion to price correctly. Given the financial impact inflation has had
Business WireTrupanion Primed and Ready to Provide Coverage for Lifesaving Medication for Feline Infectious Peritonitis
SEATTLE, May 15, 2024--Trupanion (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, is poised to increase access for Trupanion members to lifesaving medications for treatment of otherwise deadly Feline Infectious Peritonitis (FIP). Trupanion has been providing coverage where the medications are already commercially available in Australia and Canada and is ready to continue fighting FIP in the United States in June.
GuruFocus.comInsider Buying: CEO Darryl Rawlings Acquires Shares of Trupanion Inc (TRUP)
On May 7, 2024, Darryl Rawlings, Chief Executive Officer of Trupanion Inc (NASDAQ:TRUP), purchased 20,700 shares of the company, as reported in the SEC Filing.
